These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 24663052)

  • 1. Paraneoplastic focal segmental glomerulosclerosis in sarcomatoid renal cell cancer.
    Tucci M; Stucci S; Vallarelli S; Gesualdo L; Brunetti O; Dei Tos AP; Silvestris F
    J Clin Oncol; 2015 May; 33(14):e66-70. PubMed ID: 24663052
    [No Abstract]   [Full Text] [Related]  

  • 2. Widespread metastases from sarcomatoid renal cell carcinoma detected by (18)F-FDG positron emission tomography/computed tomography.
    Hyodo T; Sugawara Y; Tsuda T; Yanagihara Y; Aoki K; Tanji N; Hirata M; Murakami M; Miyagawa M; Yokoyama M; Mochizuki T
    Jpn J Radiol; 2009 Feb; 27(2):111-4. PubMed ID: 19373542
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lupus type anticoagulant in a patient with renal cell carcinoma: an autoimmune paraneoplastic syndrome.
    Ather MH; Mithani S; Bhutto S; Adil S
    J Urol; 2002 May; 167(5):2129. PubMed ID: 11956458
    [No Abstract]   [Full Text] [Related]  

  • 4. Active chemotherapy for bone metastasis in sarcomatoid renal cell carcinoma.
    Hoshi S; Satoh M; Ohyama C; Hiramatu M; Watanabe R; Hagisawa S; Endo M; Arai Y
    Int J Clin Oncol; 2003 Apr; 8(2):113-7. PubMed ID: 12720105
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glomerulosclerosis: a paraneoplastic phenomenon?
    Loi S; Perry GJ; Standish H; Dowling J
    Nephrology (Carlton); 2004 Dec; 9(6):387-91. PubMed ID: 15663641
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immediate improvement of a persistent cough after tumor embolization for renal cell carcinoma--a rare manifestation of paraneoplastic syndrome.
    Fujikawa A; Daidoh Y; Taoka Y; Nakamura S
    Scand J Urol Nephrol; 2002; 36(5):393-5. PubMed ID: 12487750
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Paraneoplastic syndrome in renal cell carcinoma].
    Bedke J; Buse S; Kurosch M; Haferkamp A; Jäger D; Hohenfellner M
    Urologe A; 2007 Jan; 46(1):45-8. PubMed ID: 17186189
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A phase II study of gemcitabine and immunotherapy in renal cancer: preliminary results and review of the literature.
    Zustovich F; Cartei G; Dal Bianco M; De Zorzi L; Ceravolo R; Zovato S; Salmaso F; Binato S; Artioli G; Cingarlini S; Pastorelli D
    Ann Oncol; 2006 May; 17 Suppl 5():v133-6. PubMed ID: 16807442
    [No Abstract]   [Full Text] [Related]  

  • 9. Linear IgA bullous dermatosis: an association with ulcerative colitis versus renal cell carcinoma.
    Keller AS; Bouldin MB; Drage LA; Hauser SC; Davis MD
    Dig Dis Sci; 2003 Apr; 48(4):783-9. PubMed ID: 12741472
    [No Abstract]   [Full Text] [Related]  

  • 10. Cancer of the kidney.
    Zweizig SL
    Clin Obstet Gynecol; 2002 Sep; 45(3):884-91. PubMed ID: 12370630
    [No Abstract]   [Full Text] [Related]  

  • 11. [Bullous pemphigoid as a paraneoplastic syndrome. A case report in renal-cell carcinoma].
    Blum A; Wehner-Caroli J; Scherwitz C; Rassner G
    Hautarzt; 1997 Nov; 48(11):834-7. PubMed ID: 9518247
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Anemia of unknown origin: paraneoplastic?].
    Biner HL; Baumann F; Gebbers JO
    Praxis (Bern 1994); 2007 May; 96(19):779-80. PubMed ID: 17571634
    [No Abstract]   [Full Text] [Related]  

  • 13. Juxtaglomerular cell tumor: multicentric synchronous disease associated with paraneoplastic syndrome.
    Cucchiari D; Bertuzzi A; Colombo P; De Sanctis R; Faucher E; Fusco N; Pellegrinelli A; Arosio P; Angelini C
    J Clin Oncol; 2013 May; 31(14):e240-2. PubMed ID: 23547072
    [No Abstract]   [Full Text] [Related]  

  • 14. Heterogeneous response to target therapy in metastatic papillary renal cell carcinoma evaluated by morphologic and metabolic multimodality imaging: A case report.
    Naglieri E; Niccoli Asabella A; Nappi AG; Carella C; Ferrari C; Rubini G
    Medicine (Baltimore); 2019 Dec; 98(50):e18093. PubMed ID: 31852068
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Renal cell carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
    Escudier B; Kataja V;
    Ann Oncol; 2010 May; 21 Suppl 5():v137-9. PubMed ID: 20555064
    [No Abstract]   [Full Text] [Related]  

  • 16. Severe paraneoplastic hypereosinophilia in metastatic renal cell carcinoma.
    Todenhöfer T; Wirths S; von Weyhern CH; Heckl S; Horger M; Hennenlotter J; Stenzl A; Kanz L; Schwentner C
    BMC Urol; 2012 Mar; 12():7. PubMed ID: 22436420
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Paraneoplastic syndrome of renal cell carcinoma].
    Masuda F; Ohnishi T; Nakada J; Suzuki M; Mori Y; Ihzuka N; Machida T
    Nihon Hinyokika Gakkai Zasshi; 1985 Mar; 76(3):371-7. PubMed ID: 4032901
    [No Abstract]   [Full Text] [Related]  

  • 18. Diagnosis and treatment of leptomeningeal metastases in a patient with renal carcinoma responding to 5-fluorouracil and gemcitabine.
    Tippin DB; Reeves W; Vogelzang NJ
    J Urol; 1999 Jul; 162(1):155-6. PubMed ID: 10379761
    [No Abstract]   [Full Text] [Related]  

  • 19. [Not Available].
    Wörner JM; Litzlbauer D; Krombach GA
    Rofo; 2019 Aug; 191(8):754-756. PubMed ID: 30900229
    [No Abstract]   [Full Text] [Related]  

  • 20. [Positron emission tomography in oncourology].
    Ryzhkova DV; Granov AM; Karelin MI; Kostenikov NA; Shkol'nik MI; Tlostanova MS; Stanzhevskiĭ AA; Arzumanov AA
    Vestn Ross Akad Med Nauk; 2005; (9):26-32. PubMed ID: 16250328
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.